메뉴 건너뛰기




Volumn 36, Issue 4, 2005, Pages 183-191

Metformin for type 2 diabetes mellitus. Systematic review and meta-analysis;Metformina para la diabetes mellitus tipo 2. Revisión sistemática y metaanálisis

Author keywords

Biguanides; Meta analyses; Metformin; Systematic review; Type 2 diabetes mellitus

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; CHLORPROPAMIDE; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; GLIPIZIDE; HEMOGLOBIN A1C; INSULIN; MEGLITINIDE; METFORMIN; MIGLITOL; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; PLACEBO; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE; TROGLITAZONE;

EID: 27144468631     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1157/13078602     Document Type: Article
Times cited : (9)

References (44)
  • 3
    • 84990931057 scopus 로고    scopus 로고
    • Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
    • Oxford: Update Software
    • Salpeter S, Greyber E, Pasternak G, Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus (Cochrane Review). En: Cochrane Library, Issue 4. Oxford: Update Software; 2003.
    • (2003) Cochrane Library , Issue.4
    • Salpeter, S.1    Greyber, E.2    Pasternak, G.3    Salpeter, E.4
  • 4
    • 0029132285 scopus 로고
    • Worldwide experience of metformin as an effective glucose-lowering agent: A meta-analysis
    • Campbell TW, Hewlett HCS . Worldwide experience of metformin as an effective glucose-lowering agent: a meta-analysis. Diabetes Metab Rev. 1995;11 Suppl 1:57-62.
    • (1995) Diabetes Metab Rev , vol.11 , Issue.SUPPL. 1 , pp. 57-62
    • Campbell, T.W.1    Hewlett, H.C.S.2
  • 5
    • 0032929173 scopus 로고    scopus 로고
    • Efficacy of metformin in the treatment of NIDDM. Meta-analysis
    • Johansen K. Efficacy of metformin in the treatment of NIDDM. Meta-analysis. Diabetes Care. 1999;22:33-7.
    • (1999) Diabetes Care , vol.22 , pp. 33-37
    • Johansen, K.1
  • 6
    • 0042629783 scopus 로고    scopus 로고
    • What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetes
    • Shaughnessy AF, Slawson DC. What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetes. BMJ. 2003;327:266-9.
    • (2003) BMJ , vol.327 , pp. 266-269
    • Shaughnessy, A.F.1    Slawson, D.C.2
  • 8
    • 85047692188 scopus 로고
    • Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
    • Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-12.
    • (1995) JAMA , vol.273 , pp. 408-412
    • Schulz, K.F.1    Chalmers, I.2    Hayes, R.J.3    Altman, D.G.4
  • 10
    • 0034791788 scopus 로고    scopus 로고
    • Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients
    • Charpentier G, Fleury F, Kabir M, Vaur L, Halimi S. Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients. Diabet Med. 2001;18:828-34.
    • (2001) Diabet Med , vol.18 , pp. 828-834
    • Charpentier, G.1    Fleury, F.2    Kabir, M.3    Vaur, L.4    Halimi, S.5
  • 11
    • 0037363570 scopus 로고    scopus 로고
    • Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea
    • Goldstein BJ, Pans M, Rubin CJ. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea. Clin Ther. 2003;25:890-903.
    • (2003) Clin Ther , vol.25 , pp. 890-903
    • Goldstein, B.J.1    Pans, M.2    Rubin, C.J.3
  • 12
    • 0029099086 scopus 로고
    • Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus
    • The Multicenter Metformin Study Group
    • DeFronzo RA, Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med. 1995;333:541-9.
    • (1995) N Engl J Med , vol.333 , pp. 541-549
    • Defronzo, R.A.1    Goodman, A.M.2
  • 13
    • 0027935577 scopus 로고
    • Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study
    • Hermann LF, Schersten B, Bitzen PO, Kjellstrom T, Lindgärde F, Melander A. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study. Diabetes Care. 1994;17:1100-9.
    • (1994) Diabetes Care , vol.17 , pp. 1100-1109
    • Hermann, L.F.1    Schersten, B.2    Bitzen, P.O.3    Kjellstrom, T.4    Lindgärde, F.5    Melander, A.6
  • 14
    • 0031460261 scopus 로고    scopus 로고
    • Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: The Essen-II Study
    • Hoffmann J, Spengler M. Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study. Am J Med. 1997;103:483-90.
    • (1997) Am J Med , vol.103 , pp. 483-490
    • Hoffmann, J.1    Spengler, M.2
  • 15
    • 0035374524 scopus 로고    scopus 로고
    • The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes
    • Chiasson JL Nadtich L, for the Miglitol Canadian University Investigator Group. The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes. Diabetes Care. 2001;24:989-94.
    • (2001) Diabetes Care , vol.24 , pp. 989-994
    • Chiasson, J.L.1    Nadtich, L.2
  • 16
    • 0037683740 scopus 로고    scopus 로고
    • Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes
    • Pavo I, Jermendy G, Varkonyi TT, Kerenyi Z, Gyimesi A, Shoustov S, et al. Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes. J Clin Endocrinol Metab. 2003;88:1637-45.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 1637-1645
    • Pavo, I.1    Jermendy, G.2    Varkonyi, T.T.3    Kerenyi, Z.4    Gyimesi, A.5    Shoustov, S.6
  • 17
    • 0035167387 scopus 로고    scopus 로고
    • Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension
    • Uehara MH. Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension. Diabetes Obes Metab. 2001;3:319-25.
    • (2001) Diabetes Obes Metab , vol.3 , pp. 319-325
    • Uehara, M.H.1
  • 18
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
    • Turner RC, Holman RR, Stratton IM, Cull CA, Matthews DR, Manley SE, et al, for the UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-65.
    • (1998) Lancet , vol.352 , pp. 854-865
    • Turner, R.C.1    Holman, R.R.2    Stratton, I.M.3    Cull, C.A.4    Matthews, D.R.5    Manley, S.E.6
  • 19
    • 0024809869 scopus 로고
    • Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients
    • Collier A, Watson HH, Patrick AW, Ludlam CA, Clarke BF. Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabete Metab. 1989;15:420-25.
    • (1989) Diabete Metab , vol.15 , pp. 420-425
    • Collier, A.1    Watson, H.H.2    Patrick, A.W.3    Ludlam, C.A.4    Clarke, B.F.5
  • 20
    • 0025903612 scopus 로고
    • Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD
    • Noury J, Nandeuil A. Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD. Diabete Metab. 1991;17(1 Pt 2):209-12.
    • (1991) Diabete Metab , vol.17 , Issue.1 PART 2 , pp. 209-212
    • Noury, J.1    Nandeuil, A.2
  • 21
    • 0032995666 scopus 로고    scopus 로고
    • Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes
    • Tessier D, Maheux P, Khalil A, Fulop T. Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes. Metabolism. 1999;48:897-903.
    • (1999) Metabolism , vol.48 , pp. 897-903
    • Tessier, D.1    Maheux, P.2    Khalil, A.3    Fulop, T.4
  • 23
    • 0034464263 scopus 로고    scopus 로고
    • The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus
    • Amador-Licona N, Guizar-Mendoza J, Vargas E, Sanchez-Camargo G, Zamora-Mata L. The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus. Arch Med Res. 2000;31:571-5.
    • (2000) Arch Med Res , vol.31 , pp. 571-575
    • Amador-Licona, N.1    Guizar-Mendoza, J.2    Vargas, E.3    Sanchez-Camargo, G.4    Zamora-Mata, L.5
  • 24
    • 0031545128 scopus 로고    scopus 로고
    • Normoglucemia en diabetes mellitus no dependiente de insulina de reciente diagnóstico. Tratamiento no farmacológico vs. tratamiento farmacológico
    • Támez Pérez HE, Gómez de Ossio MD, Ibarra Martínez IB. Normoglucemia en diabetes mellitus no dependiente de insulina de reciente diagnóstico. Tratamiento no farmacológico vs. tratamiento farmacológico. Med Int Mex. 1997;13:272-5.
    • (1997) Med Int Mex , vol.13 , pp. 272-275
    • Támez Pérez, H.E.1    Gómez De Ossio, M.D.2    Ibarra Martínez, I.B.3
  • 25
    • 27144536879 scopus 로고
    • A randomized trial tolbutamide and metformin for persistent severe hyperglycaemia in non insulin dependent diabetes mellitus (NIDDM)
    • Dalzell GW, Hadden DR, Atkinson AB, Kennedy L, Weavwe JA. A randomized trial tolbutamide and metformin for persistent severe hyperglycaemia in non insulin dependent diabetes mellitus (NIDDM). Irish J Med Sci. 1986;155:341-2.
    • (1986) Irish J Med Sci , vol.155 , pp. 341-342
    • Dalzell, G.W.1    Hadden, D.R.2    Atkinson, A.B.3    Kennedy, L.4    Weavwe, J.A.5
  • 26
    • 3543004668 scopus 로고    scopus 로고
    • Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin
    • Damsbo P, Hermann LS, Vaag A, Hother-Nielsen O, Beck-Nielsen H. Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin. Diabetes Care. 1998;21:1489-94.
    • (1998) Diabetes Care , vol.21 , pp. 1489-1494
    • Damsbo, P.1    Hermann, L.S.2    Vaag, A.3    Hother-Nielsen, O.4    Beck-Nielsen, H.5
  • 27
    • 0037346965 scopus 로고    scopus 로고
    • Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patients
    • Del Prato S, Erkelens DW, Leutenegger M. Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patients. Acta Diabetol. 2003;40:20-7.
    • (2003) Acta Diabetol , vol.40 , pp. 20-27
    • Del Prato, S.1    Erkelens, D.W.2    Leutenegger, M.3
  • 28
    • 0025763252 scopus 로고
    • Double-blind evaluation of efficacy and tolerability of metformin in NIDDM
    • Dornan TL, Heller SR, Peck GM, Tattersall RB. Double-blind evaluation of efficacy and tolerability of metformin in NIDDM. Diabetes Care. 1991;14:342-4.
    • (1991) Diabetes Care , vol.14 , pp. 342-344
    • Dornan, T.L.1    Heller, S.R.2    Peck, G.M.3    Tattersall, R.B.4
  • 29
    • 0030022720 scopus 로고    scopus 로고
    • The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes
    • Grant PJ. The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes. Diabetes Care. 1996;19:64-6.
    • (1996) Diabetes Care , vol.19 , pp. 64-66
    • Grant, P.J.1
  • 30
    • 0036895990 scopus 로고    scopus 로고
    • Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes
    • Hallsten K, Virtanen KA, Lonnqvist F, Sipila H, Oksanen A, Viljanen T, et al. Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes. Diabetes. 2002;51:3479-85.
    • (2002) Diabetes , vol.51 , pp. 3479-3485
    • Hallsten, K.1    Virtanen, K.A.2    Lonnqvist, F.3    Sipila, H.4    Oksanen, A.5    Viljanen, T.6
  • 31
    • 0033754777 scopus 로고    scopus 로고
    • Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes
    • Horton ES, Clinkingbeard C, Gatlin M, Foley J, Mallows S, Shen S. Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes. Diabetes Care. 2000;23:1660-5.
    • (2000) Diabetes Care , vol.23 , pp. 1660-1665
    • Horton, E.S.1    Clinkingbeard, C.2    Gatlin, M.3    Foley, J.4    Mallows, S.5    Shen, S.6
  • 32
    • 0031614038 scopus 로고    scopus 로고
    • Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes
    • Lee A, Morley JE. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Obes Res. 1998;6:47-53.
    • (1998) Obes Res , vol.6 , pp. 47-53
    • Lee, A.1    Morley, J.E.2
  • 33
    • 0035312620 scopus 로고    scopus 로고
    • Improved endothelial function with metformin in type 2 diabetes mellitus
    • Mather KJ, Verma S, Anderson TJ. Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol. 2001;37:1344-50.
    • (2001) J Am Coll Cardiol , vol.37 , pp. 1344-1350
    • Mather, K.J.1    Verma, S.2    Anderson, T.J.3
  • 34
    • 0025893874 scopus 로고
    • Prospective randomized two-years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes
    • Teupe B, Bergis K. Prospective randomized two-years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes. Diabetes Metab. 1991;17:213-7.
    • (1991) Diabetes Metab , vol.17 , pp. 213-217
    • Teupe, B.1    Bergis, K.2
  • 35
    • 0345434811 scopus 로고    scopus 로고
    • Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes
    • Moses R, Slobodniuk R, Boyages S, Colagiuri S, Kidson W, Carter J, et al. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care. 1999;22:119-24.
    • (1999) Diabetes Care , vol.22 , pp. 119-124
    • Moses, R.1    Slobodniuk, R.2    Boyages, S.3    Colagiuri, S.4    Kidson, W.5    Carter, J.6
  • 36
    • 0032568257 scopus 로고    scopus 로고
    • Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus
    • Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, et al. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med. 1998;338:867-72.
    • (1998) N Engl J Med , vol.338 , pp. 867-872
    • Inzucchi, S.E.1    Maggs, D.G.2    Spollett, G.R.3    Page, S.L.4    Rife, F.S.5    Walton, V.6
  • 37
    • 0029905092 scopus 로고    scopus 로고
    • Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas
    • Fanghanel G, Sánchez-Reyes L, Trujillo C, Sotres D, Espinosa-Campos J. Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas. Diabetes Care. 1996;19:1185-9.
    • (1996) Diabetes Care , vol.19 , pp. 1185-1189
    • Fanghanel, G.1    Sánchez-Reyes, L.2    Trujillo, C.3    Sotres, D.4    Espinosa-Campos, J.5
  • 38
    • 0028659004 scopus 로고
    • Operating characteristics of a rank correlation test for publication bias
    • Begg CB, Mazundar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.
    • (1994) Biometrics , vol.50 , pp. 1088-1101
    • Begg, C.B.1    Mazundar, M.2
  • 39
    • 0030922816 scopus 로고    scopus 로고
    • Bias in meta-analysis detected by a simple, graphical test
    • Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
    • (1997) BMJ , vol.315 , pp. 629-634
    • Egger, M.1    Davey Smith, G.2    Schneider, M.3    Minder, C.4
  • 41
    • 0041589516 scopus 로고    scopus 로고
    • Combination treatment with metformin and glibenclamide versus single-drug therapies in type 2 diabetes mellitus: A randomized double-blind, comparative study
    • Tosi F, Muggeo M, Brun E, et al. Combination treatment with metformin and glibenclamide versus single-drug therapies in type 2 diabetes mellitus: a randomized double-blind, comparative study. Metabolism. 2003;52:862-7.
    • (2003) Metabolism , vol.52 , pp. 862-867
    • Tosi, F.1    Muggeo, M.2    Brun, E.3
  • 42
    • 0034678773 scopus 로고    scopus 로고
    • Combinig insulin and oral agents
    • Buse J. Combinig insulin and oral agents. Am J Med. 2000;108 Suppl 6A:23-32.
    • (2000) Am J Med , vol.108 , Issue.SUPPL. 6A , pp. 23-32
    • Buse, J.1
  • 43
    • 18144447850 scopus 로고    scopus 로고
    • Antiatherogenic properties of metformin: The experimental evidence
    • Mamputu JC, Wiernsperger NF, Renier G. Antiatherogenic properties of metformin: the experimental evidence. Diabetes Metab. 2003;29(4 Pt 2):6S71-6.
    • (2003) Diabetes Metab , vol.29 , Issue.4 PART 2
    • Mamputu, J.C.1    Wiernsperger, N.F.2    Renier, G.3
  • 44
    • 0032511580 scopus 로고    scopus 로고
    • Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
    • UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-13.
    • (1998) BMJ , vol.317 , pp. 703-713


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.